These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29329108)

  • 1. Cracking novel shared targets between epilepsy and Alzheimer's disease: need of the hour.
    Garg N; Joshi R; Medhi B
    Rev Neurosci; 2018 Jun; 29(4):425-442. PubMed ID: 29329108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer's Disease-Related Epileptic Seizures.
    Lin R; Jones NC; Kwan P
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer's Disease.
    Paudel YN; Angelopoulou E; Jones NC; O'Brien TJ; Kwan P; Piperi C; Othman I; Shaikh MF
    ACS Chem Neurosci; 2019 Oct; 10(10):4199-4212. PubMed ID: 31532186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.
    Chin J; Scharfman HE
    Epilepsy Behav; 2013 Mar; 26(3):343-51. PubMed ID: 23321057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
    J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
    Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.
    Kandimalla R; Thirumala V; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1078-1089. PubMed ID: 27567931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.
    Altuna M; Olmedo-Saura G; Carmona-Iragui M; Fortea J
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
    Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
    Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.